Showing 1 to 2 of 2 results


New Drug Shows Promise in Treating Lung Cancer in Non-Smokers
A clinical trial of the drug zongertinib shows promise in treating HER2-mutated lung cancer in non-smokers, with 70% of participants experiencing tumor shrinkage; this offers hope for a previously difficult-to-treat cancer subtype that affects approximately 6,000 non-smokers annually in Spain.
New Drug Shows Promise in Treating Lung Cancer in Non-Smokers
A clinical trial of the drug zongertinib shows promise in treating HER2-mutated lung cancer in non-smokers, with 70% of participants experiencing tumor shrinkage; this offers hope for a previously difficult-to-treat cancer subtype that affects approximately 6,000 non-smokers annually in Spain.
Progress
44% Bias Score

Lung Cancer Rise in Non-Smoking Women Linked to Air Pollution and Genetic Factors
A new study shows a sharp rise in lung cancer among non-smoking women globally, with adenocarcinoma accounting for almost 60% of cases, linked to air pollution, genetic mutations (EGFR, ALK, ROS1, TP53, KRAS), and immune system factors; approximately 2.5 million new cases were reported in 2022.

Lung Cancer Rise in Non-Smoking Women Linked to Air Pollution and Genetic Factors
A new study shows a sharp rise in lung cancer among non-smoking women globally, with adenocarcinoma accounting for almost 60% of cases, linked to air pollution, genetic mutations (EGFR, ALK, ROS1, TP53, KRAS), and immune system factors; approximately 2.5 million new cases were reported in 2022.
Progress
40% Bias Score
Showing 1 to 2 of 2 results